Engineered tissues and strategies to overcome challenges in drug development.

Authors:
Khalil AS; Jaenisch R; Mooney DJ.

Journal:
Adv Drug Deliv Rev

Publication Year: 2020

DOI:
10.1016/j.addr.2020.09.012

PMCID:
PMC7518978

PMID:
32987094

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Adv Drug Deliv Rev

Abbreviation: Adv Drug Deliv Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Drug Therapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y. (2023) - Transparency Score: 3/6
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery.
Han G; Noh D; Lee H and 4 more (2023) - Transparency Score: 3/6
Imaging drug delivery to the lungs: Methods and applications in oncology.
Man F; Tang J; Swedrowska M and 2 more (2022) - Transparency Score: 3/6
In vivo fate and intracellular trafficking of vaccine delivery systems.
Lee J; Kim D; Byun J and 3 more (2022) - Transparency Score: 3/6
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.
Aldarondo D; Wayne E. (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"A.S.K. would like to acknowledge funding from the US National Institutes of Health (Grant: T32 EB016652) and David G. Belair for helpful discussions regarding industry-relevant considerations in developing models for preclinical studies. D.J.M. would like to acknowledge funding from the US National Institutes of Health (Grants: 5U01CA214369, 1R01CA223255, and 1R01FD006589). R.J. would like to acknowledge funding from the US National Institutes of Health (Grants: R37HD045022, 1R01-NS088538, and 5R01-MH104610). Figures were generated using BioRender.com and Adobe Illustrator, both of which are licensed through the Whitehead Institute for Biomedical Research."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025